Clinical Trial

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

Study acronym: ADROIT
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
Protocol Amendment History 24 amendments
This ClinicalTrials.gov record has been amended 24 times since 2019-08-26; most recent amendment 2026-01-07.
Status change: Not Yet Recruiting → Recruiting 2019-10-15
Trial Details
NCT Number NCT04071847
Lead Sponsor Abbott Medical Devices
Conditions Movement Disorders, Parkinson Disease, Essential Tremor, Tremor, Dystonia, Primary Dystonia, Secondary Dystonia
Enrollment 1,000 participants
Start Date 2019-11-26
Primary Completion 2029-09 (estimated)
Study Completion 2030-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-08